30-Jun-2009
Global
Technology Research
D19A-01-00-00-00
HC01267-GL-TR_05496
This research service outlines the key global developments in the field of biomarkers.
Macroscopic View of Biomarkers
- Go Biological with a Biomarker
- Types of Biomarkers
- Omics to Know-Omics Now
Scope and Methodology
- Scope and Segmentation of the Research Service
- Research Methodology
The Biomarker Method in Drug Discovery and Development
Noteworthy Innovations
- Biomarkers May Relieve the Drug Discovery Bottleneck
- See Path to a Biomarker
Case Studies of Targeted Diagnostics for Targeted Therapeutics
- Biomarker Serves as a Green Signal for a Small Molecule Drug and a Red Alert for Another
- Stack of Biomarkers Aid in Understanding Drug Toxicity
- Proteins Find it Difficult to Remain Undetected
- A Clear Vision and View for Metabolomics
The Biomarker Role in Clinical Diagnostics
Application Trend Analysis
AHP--Prioritization of Biomarker Technologies
Force Field Analysis
Strategic Evaluation of Patents
Key Contacts and Appendix
Database Tables
Speak directly with our analytics experts for tailored recommendations.
Recent related Life Sciences research
13 Jan 2025 | Global | Market Outlook
Top 6 Growth Opportunities for the Digital Health Industry, 2025
Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...
17 Dec 2024 | Global | Market Research
Cybersecurity in Healthcare, United States, 2024
Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...
12 Dec 2024 | Global | Market Outlook
Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025
Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...
05 Dec 2024 | Global | Frost Radar
Frost Radar™: Enterprise Conversational AI in Healthcare, 2024
This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-care, a...
27 Nov 2024 | Global | Market Research
Generative AI in Payer and Provider IT Transformation, Global, 2024-2029
The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Technology Research |
|---|---|
| No Index | Yes |
| Podcast | No |
| Industries | Healthcare |
| WIP Number | D19A-01-00-00-00 |
| Is Prebook | No |
Advances in Biomarkers (Technical Insights)
$4,950.00
Special Price $3,712.50 save 25 %